![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 36, 32791-32798, September 6, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, December 21, 2001, and in revised form, June 26, 2002
Hypoxia is a critical event for higher organisms,
and cells and tissues react by increasing the oxygen supply by
vasodilatation, angiogenesis, and erythropoiesis and maintaining
cellular energy by increasing glycolysis and inhibiting anabolic
pathways. Stimulation of glycolysis has been regarded as the main
response that increases energy production during hypoxia; however,
there is an obvious conflict during ischemia, because both the oxygen
and glucose supply are insufficient. In this study, we found that
exposure of HepG2 cells and normal fibroblasts to hypoxia induces
cellular tolerance to glucose starvation. The tolerance induced by
hypoxia is dependent on several amino acids, indicating a switch from glucose to amino acids as the energy source. When antisense RNA expression vector for 5'-AMP-activated protein kinase or protein kinase
B/Akt was transfected into HepG2 cells, the induction of tolerance to
glucose was greatly inhibited, indicating that the tolerance was
dependent on 5'-AMP-activated protein kinase and protein kinase B/Akt.
Similar tolerance was induced by nitric oxide exposure. The tolerance
induced was observed in various cells and may represent a previously
unknown physiological response related to hypoxia-preconditioning and
tumor progression:austerity.
The oxygen supply to cells and tissues is pivotal in maintaining
their function and integrity, and cellular reactions to hypoxia have
been studied extensively (1, 2). Basically, the reactions of tissues
are classified into two categories: 1) improvement of the oxygen supply
and 2) adaptation to anaerobic conditions. Reactions that improve the
oxygen supply include vasodilatation, erythropoiesis, and angiogenesis,
and adaptation reactions to anaerobic conditions include a
metabolic switch to anaerobic glycolysis, repression of anabolism, and
cell cycle arrest. These reactions are governed by various reactions,
both physiological and biochemical.
The hypoxia response is very important to understanding tumor tissue
biology. Tumor cells are continuously exposed to hypoxia, because the
oxygen demand of tumors always exceeds their supply due to their
unregulated growth caused by genetic and epigenetic alterations (3, 4).
That is why angiogenesis is so critical for tumor progression and why
anti-angiogenesis is regarded as such a promising novel strategy for
cancer therapy (5). Although the results of studies of the hypoxia
response thus far provide a good explanation for the survival strategy
of tissues during pure oxygen deficiency caused by high altitude and
pulmonary diseases, it is still difficult to explain fully the adaptive
reactions of tumor tissue. This is particularly true of hypovascular
tumors, such as pancreatic cancer, in which even the liver metastases are hypovascular (6). Because of the chronic oxygen deficiency due to
increased demand as a result of cancer growth or insufficient angiogenesis, the supply of both oxygen and nutrients may be
insufficient. The only known response of energy metabolism to hypoxia
is a switch to anaerobic glycolysis (7), but what is the source of the glucose? Most is supplied by the bloodstream, and utilization of
glycogen stores and gluconeogenesis are alternatives. Glycogen storage
in tumor tissue is generally very limited, and it is unimaginable that
glycogen could be the main source of glucose in tumors during chronic
hypoxia. Glutamine is suspected of being the main energy source in
tumors (8), but it is most efficiently used for energy production under
aerobic conditions (9). Thus cells and tissues, such as those of
tumors, are confronted by an insufficiency of both oxygen and
nutrients, and the switch to glycolysis seems inadequate to explain the
adaptation. Repeated brief exposure of organs to ischemia has been
found to confer strong tolerance to subsequent ischemia and is referred
to as "ischemic preconditioning" (10). We therefore suspected that
hypoxia might induce other reactions that confer tolerance to glucose
insufficiency. Our primary purpose in the present study was to
determine how cells respond to insufficient supplies of oxygen and nutrients.
Nitric oxide (NO)1 has been
found to be a mediator of vasodilatation (11). It also blocks apoptosis
under certain conditions (12), stimulates vascular endothelial growth
factor gene expression (13), and inhibits cytochrome oxidase activity
(14), resulting in destruction of mitochondria without cell death (15).
Based on these findings, we speculated that NO might activate some
unknown pathway that generates energy without consuming oxygen, and
therefore might be a mediator of cellular responses to an insufficient
blood supply.
In the present study, we examined the effects of hypoxia and NO on the
cellular response to nutrient deprivation to determine whether there
are any unknown physiological adaptations of cells to overcome
deprivation of both oxygen and nutrients.
Cells and Culture--
HepG2 cells were obtained from
Japanese Collection of Research Bioresources, and WI-38 cells
were purchased from ATCC. All cells were maintained under the standard
culture conditions recommended by the suppliers. When nutrient
starvation had been achieved, cells were seeded into 12-well dishes
(Falcon). After 24 h, the cells were washed with
phosphate-buffered saline, and the medium was changed to either DMEM
(Invitrogen) supplemented with 10% dialyzed FCS (Sigma), minimum
Eagle's medium nonessential amino acid mixture (Invitrogen), glutamine
and antibiotic mixture (Invitrogen), or DMEM-base with the same
supplements as above.
S-Nitroso-N-acetyl-DL-penicillamine (SNAP) was dissolved in dimethyl sulfoxide
(Me2SO4) to create a 1 M stock
solution, and it was frozen at Analysis of Organic Acids--
Organic acids in the culture
medium were analyzed after a 24-h culture of cells in 10-cm plastic
dishes with DMEM supplemented with 10% FCS with or without addition of
SNAP. The organic acid fraction was prepared by addition of perchloric
acid to a final concentration of 1%. The precipitate was removed by
centrifugation and filtration through a filter having a 0.45-µm pore
size. The filtrate was then subjected to HPLC analysis on a Shodex
column KC-811 (YMC Co. Ltd., Kyoto, Japan). In some experiments,
lactate was determined with a kit from Sigma. The 1% O2
culture was conducted in a humidified incubator under 1%
O2, 5% CO2, and 94% N2.
Antisense RNA Expression Vectors and Transfection--
The
antisense RNA expression vectors for Akt1 and Akt2 were constructed as
described previously (16). Briefly, the cDNAs for Akt1 and Akt2
were ligated into pCR3 vector (Invitrogen) in an antisense orientation.
Similarly, cDNA for AMPK Western Blot Analysis of Akt Protein--
The total amounts of
Akt protein and phosphorylated Akt were determined by Western blot
analysis as described previously (16) using Akt-specific and
Ser-473-phosphorylated Akt-specific antisera (New England Biolabs).
Antisera against AMPK AMPK Activity Determination--
AMPK activity was assayed
essentially based on the method of Davies et al. (17) using
SAMS peptide as the substrate, with modifications. The details of the
modifications will be published elsewhere, but briefly are as follows.
Glutathione S-transferase-SAMS fusion protein expressed in
E. coli was used as the substrate instead of synthetic SAMS
peptide. GST-SAMS fusion protein was prepared by constructing an
expression vector having a cDNA coding for SAMS peptide at the
3'-end of the glutathione S-transferase of pGEX vector and
transfecting it into E. coli. The fusion protein was
purified by glutathione-Sepharose (Amersham Biosciences) column chromatography after extraction. After the AMPK enzyme reaction, GST-SAMS fusion protein was recovered by binding to
glutathione-Sepharose and precipitation by centrifugation.
Radioactivity was determined with a liquid scintillation counter
(Beckman Instruments).
Electromobility Shift Assay of HIF-1--
The DNA binding
activity of HIF-1 was assessed by electromobility shift assay,
essentially based on the method described previously (18). HepG2 cells
exposed to 30 µM CoCl2 or 200 µM desferrioxamine in DMEM at atmospheric oxygen tension
or cultured at 1% oxygen for 12 h were used or HepG2 cells
cultured in DMEM or DMEM-base either at atmospheric or 1% oxygen
tension for 12 h.
Statistical Analysis--
All of the data were analyzed by
unpaired Student's t test where possible, and differences
with a p value of <0.05 were considered significant.
Reagents--
S-Nitroso-N-acetyl-DL-penicillamine
(SNAP) and N-acetyl-DL-penicillamine
were purchased from Dojindo, Kumamoto, Japan. D-Glucose, 2-deoxy-D-glucose, D-glucosamine, and
N-acetyl-D-glucosamine were purchased from Sigma
and were more than 99% pure.
Exposure to Hypoxia and NO Confer Tolerance to Glucose
Starvation--
As shown in Fig.
1a, when human hepatoma HepG2
cells were cultured in glucose-free Dulbecco's modified Eagle's
medium supplemented with 10% dialyzed fetal calf serum at the
atmospheric oxygen concentration with 5% CO2, most of the
cells underwent necrotic cell death within 24 h. However, under
1% O2, 5% CO2 and 94% N2, the
cells survived much longer (Fig. 1a), and the surviving
cells grew normally upon addition of glucose. There was a significant
increase in cell survival when 0.5 mM or 0.25 mM SNAP, an NO generator, was included in the culture
medium (Fig. 1b). Because NO strongly inhibits cytochrome
c oxidase and hypoxia limits oxygen utilization, cells were
exposed to various concentrations of NaCN, a specific inhibitor of
cytochrome c oxidase, to assess its effect on survival (Fig. 1c); however, it did not affect cell survival up to 4 mM, at which concentration oxygen consumption was
completely blocked, the same as with 0.5 mM SNAP (data not
shown). SNAP is an NO generator but also produces
N-acetyl-DL-penicillamine as a by-product and nitrite as an oxidized product of NO; however, these products alone had
negligible effects on cell survival (data not shown). NaCN did not
alter cell survival, but 0.5 mM SNAP enhanced cell survival
even at low oxygen concentrations (1%). The half-life of NO and the
release of NO from SNAP are greatly influenced by the oxygen
concentration (19). When the effect of NO on cell survival under 1%
O2 was examined at various SNAP concentrations, SNAP was
found to enhance cell survival at much lower concentrations (Fig.
1d), and a clear additive effect of SNAP and hypoxia was seen under these conditions. By contrast, the high concentration of
SNAP was cytotoxic at both atmospheric and hypoxic oxygen tension (Fig.
1d).
Glycolysis has long been considered the major pathway of energy
production under hypoxic conditions, and consistent with this, when
glucose was present accumulation of the glycolytic products lactate and
acetate was greatly increased under 1% O2 and/or in the
presence of SNAP (Table I). As shown in
Fig. 2, NO again prolonged the survival
of cells exposed to 5 µM iodoacetate, a strong inhibitor
of glycolysis (Fig. 2a). This enhanced cell survival was
reproduced by hypoxia but not by NaCN. Similar prolonged cell survival
was also observed with WI-38 human fibroblasts (Fig. 2b).
WI-38 cells exposed to 5 µM iodoacetate alone formed
blebs within 6 h and died shortly thereafter. NaCN did not alter
this cell death, but cells treated with both iodoacetate and SNAP
maintained their morphology and viability until 24 h and died only
after 48 h. These results clearly indicate that the glycogen
utilization is not the mechanism of the enhanced survival.
Induction of Tolerance to Glucose Starvation Is Dependent on Amino
Acids--
Another possible mechanism of the improved cell survival is
enhanced utilization of amino acids or fatty acids for energy production. To test this possibility, we conducted a series of experiments in which amino acids, fatty acids, or both were withdrawn from the cell culture. When all amino acids were present, there was
clear hypoxia-induced tolerance (Fig.
3a). The same observations were made in HLE human hepatoma cells (data not shown) and
showed that amino acids are essential for induction of tolerance.
Accordingly, experiments were conducted with medium supplemented with
only one amino acid and no serum. When cells were cultured at
atmospheric oxygen tension, they all died, whereas significant numbers
of cells survived during hypoxia in the presence of certain amino acids, including glutamine, arginine, serine, cystine, proline, glutamic acid, and aspartic acid (Fig. 3b). When a fatty
acid mixture was included in the medium, cell survival was slightly enhanced under normoxic conditions but not under hypoxic conditions (data not shown).
HIF-1 Activation Might Not be Involved in the Induction of
Tolerance--
Both hypoxia and exposure to NO activate the
hypoxia-response transcription factor, HIF-1. HIF-1 activates a series
of genes encoding glycolytic enzymes and the glucose transporter, and
probably also modulates a series of genes whose products shift energy
metabolism away from glycolysis. Cobalt chloride and desferrioxamine
are known to activate HIF-1, but neither compound induced tolerance (Fig. 4a) despite clearly
activating HIF-1, as shown in Fig. 4b. HIF-1 was also
clearly activated by exposure to NO or hypoxia in the presence of
glucose, but relatively weakly activated in the absence of glucose
(Fig. 4c). All these findings suggest that HIF-1 activation
is insufficient for induction of tolerance, and it does not seem to be
involved in tolerance.
AMPK Is Involved in the Induction of Tolerance--
AMPK was
examined for possible involvement in tolerance because it is a
heterotrimeric serine-threonine protein kinase that is activated under
various stress conditions under which the cellular ATP level decreases.
The AMPK activity of parental HepG2 cells and HepG2 cells transfected
with the control vector pCR3.0 slightly decreased after glucose
starvation but increased significantly in response to hypoxia or SNAP
even after glucose starvation (Table II).
When an antisense RNA expression vector for the PKB/Akt Is Also Involved in the Tolerance
Mechanism--
PKB/Akt is known to be involved in the cell survival
reaction under various stress conditions, and we previously discovered (16) that PKB/Akt is involved in the tolerance of pancreatic cancer
cells to nutrient starvation. In this study we investigated the
possibility that PKB/Akt is also involved in the mechanisms of
tolerance. PKB/Akt was found to be phosphorylated strongly during
glucose starvation, both under normoxic and hypoxic conditions, and the
PKB/Akt phosphorylation was inhibited by the PI3-kinase inhibitor
wortmannin but not by the mTOR inhibitor rapamycin or the AMPK
inhibitor adenosine arabinoside (Fig.
6a). These findings strongly
suggest that PKB/Akt might be involved in the sensing mechanisms in a
PI3-kinase-dependent fashion. Based on the above findings,
antisense expression vectors for Akt1 and Akt2 were transfected into
HepG2 cells, and as expected, induction of tolerance to glucose
starvation was markedly inhibited in the HepG2 cells transfected with
the Akt1 antisense expression vector but not in the cells transfected
with Akt2 antisense expression vector (Fig. 6b). The amount
of total Akt protein expression in both transfectants and the parental
HepG2 cells was examined by Western blot analysis, but the amounts had
not changed significantly (Fig. 6c). When wild-type sense
expression vectors for Akt1 and the constitutive active fragment of
AMPK The present work clearly showed that exposure to NO and/or hypoxia
clearly conferred tolerance to glucose starvation in both normal and
cancer cell lines. This result is paradoxical because it has long been
believed that glycolysis is the main mechanism for energy production
when oxygen consumption is restricted. Restriction of oxygen
consumption can also be achieved with cyanide, which strongly inhibits
cytochrome c oxidase. However, cyanide did not confer any
protective effect on cell survival during glucose starvation. These
findings strongly suggest that hypoxia and/or NO might induce a
previously known biological response to an insufficient oxygen and
nutrient supply (famine response).
HIF-1 is a key molecule in the hypoxia response, and both hypoxia and
NO activate HIF-1 (18). It therefore seemed reasonable to hypothesize
that HIF-1 is also a key molecule in the induction of tolerance.
However, HIF-1 activation is insufficient to induce tolerance, because
CoCl2 and desferrioxamine clearly activated HIF-1 but did
not induce tolerance to glucose starvation, and it was not activated
effectively during glucose starvation. By contrast, the AMPK activator
5-aminoimidazole-4-carboxamide-1- A transforming growth factor The results of this study clearly show that AMPK is involved in the
induction of tolerance to glucose starvation, but how it is involved is
not yet clear. Because AMPK is activated by various metabolic stresses,
the AMPK pathway may be the primary sensor of hypoxia and glucose
starvation and mediate subsequent responses (24). Actually, the AMPK
activator
5-aminoimidazole-4-carboxamide-1- The present study showed that the tolerance to glucose starvation was
dependent on amino acids. Some tumors are known to utilize glutamine
for energy production better than glucose (8), and this seems to be
consistent with our findings. However, because the biochemical
mechanisms for energy production from amino acids were analyzed mostly
during normoxia, how energy is produced from amino acids under hypoxia
remains to be elucidated. Aspartic acid was reported recently (26) to
be protective of renal tubules subjected to ischemia, and the
biochemical mechanisms for this effect was suggested to be anaerobic
respiration in which fumarate is reduced to succinate. Our own findings
may be related to this observation, but further biochemical
investigation is needed. Another important question involves the source
of the amino acids when the blood supply is restricted in
vivo. Autophagy is one of the best known biological responses to
starvation, and many organisms survive nutrient starvation by degrading
their own constituents (27). We recently found that exposing cells to
NO or nutrient starvation up-regulates some matrix
metalloproteinases.3 The
notion that degradation of the extracellular matrix supplies amino
acids to cancer cells for energy production is an interesting hypothesis.
The present findings are still preliminary, but they are quite
important from both a biological and medical viewpoint. Once the
mechanisms for induction of tolerance (austerity) are elucidated, they
will open a new field of research in regard to the prevention and
treatment of myocardial infarction, stroke, and cancer. Tolerance to
nutrient starvation might be part of the biological response to an
insufficient blood supply, and in the future it might be possible to
include it in the so-called hypoxia response, but to avoid confusion it
might be wise to call it a "famine (extreme poverty) response" for
the time being. It is also possible that the tolerance to nutrient
starvation is not restricted to glucose and that the tolerance can be
referred to as "austerity," which might cover energy production,
energy consumption, differentiation, apoptosis, and cell proliferation.
*
This work was supported in part by a grant for the Second
Term Comprehensive Strategy for Cancer Control from the Ministry of
Health and Welfare and a grant-in-aid for Cancer Research from the
Ministry of Education, Science, Sports, and Culture, Japan.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: National Cancer Center
Research Institute East, 6-5-1, Kashiwanoha, Kashiwa, Chiba 277-8577 Japan. Fax: 81-471-34-6859; E-mail: hesumi@east.ncc.go.jp.
Published, JBC Papers in Press, June 28, 2002, DOI 10.1074/jbc.M112270200
2
H. Esumi, K. Izuishi, K. Kato, K. Hashimoto, Y. Kurashima, A. Kishimoto, T. Ogura, and T. Ozawa,
unpublished data.
3
Y. Ishii, T. Ogura, F. Ohtsuka, and H. Esumi,
submitted for publication.
The abbreviations used are:
NO, nitric oxide;
PKB/Akt, protein kinase B/Akt;
AMPK, 5'-AMP-activated protein kinase;
FCS, fetal calf serum;
DMEM, Dulbecco's modified Eagle's medium;
HIF-1, hypoxia-inducible factor-1;
SNAP, N-nitroso-N-acetyl-DL-penicillamine;
HepG2/
Hypoxia and Nitric Oxide Treatment Confer Tolerance to Glucose
Starvation in a 5'-AMP-activated Protein Kinase-dependent
Manner*
§,
,
,
,
,
, and
Investigative Treatment Division, National
Cancer Center Research Institute East 6-5-1, Kashiwanoha, Kashiwa,
Chiba 277-8577 and the ¶ Department of Biochemistry, Nagoya
University School of Medicine Tsurumai-chou, Showa-ku,
Nagoya 466-8550, Japan
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
20 °C until used. The same volume
of Me2SO4 was added to control cultures. After detaching the cells from each well by trypsinization, they were counted
with a hemocytometer, and viable cells were identified by dye-exclusion
with trypan blue (Invitrogen). Hypoxia was achieved by culturing cells
under 1% O2, 5% CO2, and 94%
N2.
1 and the
2 subunit was cloned in
the antisense orientation into the XhoI/EcoRV site of pCDNA3.1 vector and the EcoRI site of pCR3.0
vector, respectively. All expression vectors were verified by
sequencing. The cDNA for AMPK
1 and
2 was obtained by reverse
transcription-coupled PCR using the following primers and the mRNA
fraction of human fetal brain (CLONTECH). The
primers for the
1 subunit were 5'-ggctcgagcctggagaaagatggcgacag-3' and 5'-ccgaatcttagtaaagacagctgagaacttcc-3' covering
11 to 942 nucleotides, and for
2 they were 5'-gaagatggctgagaagcaga-3' and 5'-aactagagacagatcaqacgg-3', covering the entire coding sequence (
4
to 1672 nucleotides). HepG2 cells were transfected with the above
expression vectors by the calcium phosphate co-precipitation method,
and selection was achieved by adding G418 (Invitrogen) at 640 µg/ml
for at least 2 weeks.
1 and
2 subunits were prepared by injecting
denatured
1 and
2 subunits into rabbits. AMPK
1 and
2
subunits were purified from Escherichia coli transfected with expression vector containing the 11-942 nucleotides of
1 subunit cDNA or the entire coding sequence (
4 to 1672 nucleotides) of
2 subunit cDNA constructed in a pET 19b vector
(Novagen) having the His tag. His-tagged subunits were purified by
nickel-nitrilotriacetic acid column chromatography and
preparative SDS-PAGE. The cross-reactivity of both sera was minimized
by absorbing them with another antigen. The details of the antibody
preparation will be published elsewhere.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (22K):
[in a new window]
Fig. 1.
Cell survival during glucose starvation.
Each cell count represents the mean of at least three independent
wells. Statistically significant differences from the respective
control in response to hypoxia or SNAP are marked * (p < 0.05) or ** (p < 0.01). a, time course
of cell death caused by glucose starvation under atmospheric oxygen and
1% oxygen.
, 1% oxygen, DMEM-base;
, atmospheric oxygen,
DMEM-base. The number of cells at the start of glucose starvation was
set equal to 100%. b, cell survival without glucose under
atmospheric oxygen, with or without SNAP.
, without SNAP;
, with
0.25 mM SNAP;
, with 0.5 mM SNAP.
c, effect of oxygen concentration, NaCN, and SNAP on cell
survival during glucose starvation. Cell viability was assessed 36 h after the start of glucose starvation. The final concentrations are
as follows: NaCN, 4 mM; SNAP, 0.5 mM.
d, effect of SNAP concentration on cell survival under
oxygen concentrations of 21 and 1%. Cells were counted after 36 h
of starvation.
Organic acid accumulation in HepG2 cell medium

View larger version (28K):
[in a new window]
Fig. 2.
Effect of SNAP on cell death induced by
iodoacetate. a, time course of cell death caused by
iodoacetate.
, cells cultured in DMEM plus 5 µM
iodoacetate;
, cells cultured in DMEM plus 5 µM
iodoacetate and 0.5 mM SNAP. Statistically significant
differences from the respective control are marked **
(p < 0.01). b, effect of SNAP and NaCN on
iodoacetate-induced cell death.
, HepG2 cells in DMEM;
, HepG2
cells in DMEM with 5 µM iodoacetate;
, HepG2 cells in
DMEM with 5 µM iodoacetate and 4 mM NaCN;
, HepG2 cells in DMEM with 0.5 mM SNAP;
, HepG2 cells
in DMEM with 5 µM iodoacetate and 0.5 mM
SNAP;
, HepG2 cells in DMEM with 5 µM iodoacetate, 4 mM NaCN, and 0.5 mM SNAP;
, WI-38 cells in
DMEM;
, WI-38 cells in DMEM with 5 µM iodoacetate;
, WI-38 cells in DMEM with 5 µM iodoacetate and 0.5 mM SNAP. These photographs were taken at 12 h.

View larger version (18K):
[in a new window]
Fig. 3.
Nutrient components required for
hypoxia-induced tolerance. a, effect of amino acids on cell
survival during glucose starvation under normoxic and hypoxic
conditions. HepG2 cells were seeded 24 h prior to starvation.
Serum was added at 10%, where indicated. The amino acid mixture was
prepared by mixing minimum Eagle's medium essential amino acid mixture
and minimum Eagle's medium non-essential amino acid mixture and added
to the medium, where indicated. Glutamine was added in the form of
glutamine stock solution, where indicated. Cells were counted after
36 h of starvation. Statistically significant differences from the
respective control by hypoxia are marked ** (p < 0.01). b, effect of single amino acid addition on cell
survival under 1% oxygen tension. Glucose, serum, succinic acid, amino
acids, and pyruvate were omitted from the culture media described (19).
Only the single amino acid indicated was added at the concentration
used in DMEM. Cells were counted after 36 h of starvation.
Statistically significant differences from control without amino acids
are marked ** (p < 0.01).

View larger version (40K):
[in a new window]
Fig. 4.
Effect of various compounds on
hypoxia-induced tolerance. a, effect of HIF-1 activator on
cell survival without glucose under atmospheric oxygen. Cobalt chloride
and desferrioxamine (DFX) were added at 30 and 200 µM, respectively. Cells were subjected to hypoxia
(HYP) at 1% oxygen. Cell survival was determined after
48 h of starvation. HepG2 cells were cultured in DMEM base
supplemented with 10% FCS and glutamine. Statistically significant
differences from the normoxic control are marked ** (p < 0.01). b, electrophoretic mobility shift assay of HIF-1.
Electrophoretic mobility shift assay was carried out as described
previously (21). NOR, normoxia; HYP, 1% oxygen;
CoCl2, cultured in CoCl2;
DFX, cultured in desferrioxamine. Nuclear extracts were
obtained from duplicate cultures after 12 h of exposure.
c, effect of glucose on HIF-1 activation. Cells were
cultured for 12 h under the conditions indicated at the
top, i.e. either normoxia (NOR) or
hypoxia (HYP) and either in the presence (+) or absence (
)
of glucose. Electrophoretic mobility shift assay was carried out as
described above.
1 or
2 subunit of
AMPK was transfected into HepG2 cells (HepG2/
1A cells and
HepG2/
2A cells, respectively), the cells grew normally in ordinary
DMEM supplemented with 10% FCS but started to die within 24 h in
glucose-free medium under normoxia, the same as the parental HepG2
cells (data not shown). As mentioned previously, however, HepG2 cells
survive much longer when cultured under 1% O2 conditions. By contrast, HepG2/
1A and HepG2/
2A cells died much sooner than HepG2 cells transfected with control vector pCR3.0 (HepG2/pCR), although the AMPK
2 antisense vector was less effective than
1
(Fig. 5a). Similar reduction
of cell survival was observed in HepG2/
1A and HepG2/
2A cells
during SNAP-induced tolerance to glucose starvation (data not shown).
The basal level of expression of each AMPK
subunit in the
respective transfectants was examined by Western blot analysis (Fig.
5b), and the expression of each of the respective isoforms
in transfectants was found to decrease slightly but significantly.
Because it is currently impossible to assay differential AMPK isotype
activity, total AMPK activity after glucose starvation at 1% oxygen
and during SNAP exposure was determined. Basal activity at the
beginning of starvation was slightly lower in HepG2/
1A cells than in
HepG2/pCR cells, but after 6 h of glucose starvation, its activity
in HepG2/
1A and HepG2/
2A cells was higher than in the HepG2/pCR
cells (Table II). When cells were exposed to either hypoxia or SNAP
during glucose starvation, AMPK activity was found to be markedly
increased in HepG2/pCR and HepG2/
1A cells but to a lesser extent in
HepG2/
2A cells during 6 h of starvation. These complicated
changes in AMPK activity indicated that AMPK activity assessed by SAMS
peptide alone does not explain the mechanisms of prolonged cell
survival under hypoxia or SNAP treatment.
AMPK activity of HepG2 cells and AMPK a1 and a2 antisense
RNA-transfected cells under various conditions
1A, HepG2 cells stably
transfected with AMPK a1 antisense RNA expression vector;
2A, HepG2
cells stably transfected with AMPK a2 antisense RNA expression vector.
The results of the statistical analyses are shown only for comparisons
among HepG2 cells under various conditions and comparisons among three
cell lines under the same conditions.

View larger version (33K):
[in a new window]
Fig. 5.
Effect of antisense RNA expression vectors
for AMPK on hypoxia-induced tolerance to glucose starvation of HepG2
cells. a, cell survival under glucose starvation at 1%
oxygen. HepG2 cells were transfected with antisense RNA expression
vectors for the
1 and
2 subunit of AMPK or control PCR3.0, and
stable transformants were obtained by G418 selection for at least 2 weeks. Cells were seeded in DMEM complete medium in 12-well plates
24 h prior to starvation and washed twice with PBS and cultured in
DMEM-base supplemented with 10% dialyzed FCS and glutamine at 1%
oxygen. The viable cell count was determined at every time indicated.
The number of the cells at the start of starvation was set equal to
100%.
, HepG2 cells stably transfected with PCR 3.0 vector;
,
HepG2 cells stably transfected with AMPK
1 antisense RNA expression
vector;
, HepG2 cells stably transfected with AMPK
2 antisense
RNA expression vector. Statistically significant differences from the
control at each time point are marked * (p < 0.05) or
** (p < 0.01). b, Western blot analysis of
AMPK
1 and
2 expression in duplicate. PCR, HepG2 cells stably
transfected with PCR 3.0 vector;
1A, HepG2 cells stably transfected
with AMPK
1 antisense RNA expression vector;
2A, HepG2 cells
stably transfected with AMPK
2 antisense RNA expression
vector.
1 were transfected into HepG2 cells, cell survival during
normoxia and glucose starvation was significantly higher, but the
effects were only minimal and transient (data not shown).

View larger version (29K):
[in a new window]
Fig. 6.
Western blot analysis of Akt and
Ser-473-phosphorylated Akt and effects of antisense RNA expression
vectors for Akt1 and Akt2 on hypoxia-induced survival of HepG2 cell
under glucose starvation. a, HepG2 cells were cultured under
the conditions indicated for 2 h before cell lysate preparation.
Glc, 1 mg/ml D-glucose; AA, amino
acids, mixture of all amino acids at the concentration used in DMEM;
rapamycin, 50 µg/ml rapamycin; wortmannin, 100 nM wortmannin; AraA, 100 µM
adenosine arabinoside. b, HepG2 transfectant survival at 1%
oxygen without glucose.
, HepG2 cells stably transfected with PCR
3.0 vector;
, HepG2 cells stably transfected with Akt1 antisense RNA
expression vector;
, HepG2 cells stably transfected with Akt2
antisense RNA expression vector. c, Western blot analysis of
Akt protein expression in duplicate. PCR, HepG2 cells stably
transfected with PCR 3.0 vector; Akt1A, HepG2 cells stably
transfected with Akt1 antisense RNA expression vector;
Akt2A, HepG2 cells stably transfected with Akt2 antisense
RNA expression vector.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-ribofuranoside strongly induced tolerance to glucose starvation, but it did not activate HIF-1 at all (20). Moreover, whereas methylene blue and
LY83583 inhibited HIF-1 activation by NO, but not by hypoxia, they
inhibited the induction of tolerance to glucose starvation by both
stimuli.2 These findings
support the notion that induction of tolerance is independent of HIF-1
activation, although its dependence on HIF-1 activation cannot be
completely ruled out until definitive results are obtained, such as in
an experiment using HIF-1 knockout cells.
-like signaling pathway through
PI3-kinase and PKB/Akt regulates Dauer larva formation in nematodes (21). Dauer larva formation is an adaptive response to harsh conditions
that is achieved by changing both the energy metabolism fo the organism
and the cell cycle program (21, 22). The PI3-kinase-PKB/Akt pathway is
also a well known tumor survival pathway (23). When activation of
PKB/Akt was examined, it was found to be activated by glucose
starvation, and similar activation was found when amino acids were
withdrawn (16). These findings suggest that the PKB/Akt pathway might
be involved in the mechanism that senses the state of nutrient
availability. Although wortmannin, an inhibitor of PI3-kinase, had no
effect on cell survival during glucose starvation, the antisense RNA
expression vector for Akt1 partially but significantly inhibited
tolerance induction, suggesting that Akt may modulate the induction of
tolerance instead of being involved in it directly. The reason the
total amount of Akt did not change significantly after transfecting
antisense RNA expression vectors remains unknown, but it may be due to
the inability to differentiate two isoforms, as shown by Western blot.
Interaction between the regulation of Akt1 and Akt2 is another possibility.
-D-ribofuranoside has
been found to strongly induce tolerance to glucose starvation in an
AMPK
2-dependent manner (20). There was an obvious
contradiction. When AMPK activity was examined with GST-SAMS fusion
protein as a substrate, it was found to be decreased in HepG2/
1A
cells but not in HepG2/
2A cells, although the amount of AMPK
subunit protein was decreased in each of the respective
antisense-transfected cells. At present, there is no method for
differentially determining the enzymatic activity of each isozyme
composed of the
1 and
2 and
and
isoforms, and this
limitation might be the source of the apparent contradiction. There may
also be interactions between
1 and
2 expression under various
stress conditions. A new member of the AMPK family, SNARK, that has
kinase activity against SAMS peptide has recently been identified, and
its activity may be another reason for the apparent contradiction (25).
It is also not known whether there is interaction or cross-talk between the Akt and AMPK pathways, but both share targets, including glucose synthetase, glucose transporter, and amino acid transporters (6). In
the present study we tested the possibility that AMPK might be
responsible for the phosphorylation of Akt with an AMPK inhibitor, adenosine arabinoside, but it had no effect on Akt phosphorylation, suggesting that AMPK is not upstream of Akt activation during nutrient starvation.
![]()
FOOTNOTES
![]()
ABBREVIATIONS
1A, HepG2 cell transfected with AMPK
1 antisense RNA
expression vector;
HepG2/
2A, HepG2 cell transfected with AMPK
2
antisense RNA expression vector;
HepG2/pCR, HepG2 cell transfected with
pCR3.0;
PI3-kinase, phosphatidylinositol 3-kinase.
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Zhu, H.,
and Bunn, H. F.
(1999)
Respir. Physiol.
115,
239-247[CrossRef][Medline]
[Order article via Infotrieve]
2.
Semenza, G. L.
(1999)
Cell
98,
281-284[CrossRef][Medline]
[Order article via Infotrieve]
3.
Hahnfeldt, P.,
Panigrahy, D.,
Folkman, J.,
and Hlatky, L.
(1999)
Cancer Res.
59,
4770-4775 4.
Dang, C. V.,
and Semenza, G. L.
(1999)
Trends Biochem. Sci.
24,
68-72[CrossRef][Medline]
[Order article via Infotrieve]
5.
Folkman, J.
(1972)
Ann. Surg.
175,
409-416[Medline]
[Order article via Infotrieve]
6.
Warshaw, A. L.,
and Fernandez-del Castillo, C.
(1992)
N. Engl. J. Med.
326,
455-465[Medline]
[Order article via Infotrieve]
7.
Bunn, H. F.,
and Poyton, R. O.
(1996)
Physiol. Rev.
76,
839-885 8.
Kovacevic, Z.,
and McGivan, J. D.
(1983)
Physiol. Rev.
63,
547-605 9.
Kallinowski, F.,
Runkel, S.,
Fortmeyer, H. P.,
Forster, H.,
and Vaupel, P.
(1987)
J. Cancer Res. Clin. Oncol.
113,
209-215[CrossRef][Medline]
[Order article via Infotrieve]
10.
Hale, S. L.,
and Kloner, R. A.
(1994)
Curr. Opin. Cardiol.
9,
411-416[Medline]
[Order article via Infotrieve]
11.
Moncada, S.
(2000)
Verh. K. Acad. Geneeskd. Belg.
62,
171-179[Medline]
[Order article via Infotrieve]
12.
Ogura, T.,
DeGeorge, G.,
Tatemichi, M.,
and Esumi, H.
(1998)
Jpn. J. Cancer Res.
89,
199-205[CrossRef]
13.
Chin, K.,
Kurashima, Y.,
Ogura, T.,
Tajiri, H.,
Yoshida, S.,
and Esumi, H.
(1997)
Oncogene
15,
437-442[CrossRef][Medline]
[Order article via Infotrieve]
14.
Cleeter, M. W.,
Cooper, J. M.,
Darley-Usmar, V. M.,
Moncada, S.,
and Schapira, A. H.
(1994)
FEBS Lett.
345,
50-54[CrossRef][Medline]
[Order article via Infotrieve]
15.
Esumi, H.,
Chin, K.,
Kurashima, Y.,
Hasegawa, F.,
Ogura, T.,
Yoneda, M.,
and Ozawa, T.
(1997)
Biochem. Mol. Biol. Int.
42,
779-787
16.
Izuishi, K.,
Kato, K.,
Ogura, T.,
Kinoshita, T.,
and Esumi, H.
(2000)
Cancer Res.
60,
6201-6207 17.
Davies, S. P.,
Carling, D.,
and Hardie, D. G.
(1989)
Eur. J. Biochem.
186,
123-128[Medline]
[Order article via Infotrieve]
18.
Kimura, H.,
Weisz, A.,
Kurashima, Y.,
Hashimoto, K.,
Ogura, T.,
D'Acquisto, F.,
Addeo, R.,
Makuuchi, M.,
and Esumi, H.
(2000)
Blood
95,
189-197 19.
Ioannidis, I.,
Batz, M.,
Paul, T.,
Korth, H. G.,
Sustmann, R.,
and De Groot, H.
(1996)
Biochem. J.
318,
789-795[Medline]
[Order article via Infotrieve]
20.
Hashimoto, K.,
Kato, K.,
Imamura, K.,
Kishimoto, A.,
Yoshikawa, H.,
Taketani, Y.,
and Esumi, H.
(2001)
Biochem. Biophys. Res. Commun.
290,
263-267[CrossRef]
21.
Larsen, P. L.,
Albert, P. S.,
and Riddle, D. L.
(1995)
Genetics
139,
1567-1583[Abstract]
22.
Gallant, J. A.
(1979)
Annu. Rev. Genet.
13,
393-415[CrossRef][Medline]
[Order article via Infotrieve]
23.
Rouault, J. P.,
Kuwabara, P. E.,
Sinilnikova, O. M.,
Duret, L.,
Thierry-Mieg, D.,
and Billaud, M.
(1999)
Curr. Biol.
9,
329-332[CrossRef][Medline]
[Order article via Infotrieve]
24.
Hardie, D. G.,
and Carling, D.
(1997)
Eur. J. Biochem.
246,
259-273[Medline]
[Order article via Infotrieve]
25.
Lefebvre, D. L.,
Bai, Y.,
Shahmolky, N.,
Sharma, M.,
Poon, R.,
Drucker, D. J.,
and Rosen, C. F.
(2001)
Biochem. J.
355,
297-305[CrossRef][Medline]
[Order article via Infotrieve]
26.
Weinberg, J. M.,
Venkatachalam, M. A.,
Roeser, N. F.,
and Nissim, I.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
2826-2831 27.
Grinde, B.
(1985)
Experientia (Basel)
41,
1089-1095
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H.-S. Kim, J.-T. Hwang, H. Yun, S.-G. Chi, S.-J. Lee, I. Kang, K.-S. Yoon, W.-J. Choe, S.-S. Kim, and J. Ha Inhibition of AMP-activated Protein Kinase Sensitizes Cancer Cells to Cisplatin-induced Apoptosis via Hyper-induction of p53 J. Biol. Chem., February 15, 2008; 283(7): 3731 - 3742. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sato, K. Tsuchihara, S. Fujii, M. Sugiyama, T. Goya, Y. Atomi, T. Ueno, A. Ochiai, and H. Esumi Autophagy Is Activated in Colorectal Cancer Cells and Contributes to the Tolerance to Nutrient Deprivation Cancer Res., October 15, 2007; 67(20): 9677 - 9684. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Hsu, H.-C. Lee, Y.-H. Ping, T.-Y. Liu, W.-Y. Lui, and C.-W. Chi Mitochondria Are an Essential Mediator of Nitric Oxide/Cyclic Guanosine 3',5'-Monophosphate Blocking of Glucose Depletion Induced Cytotoxicity in Human HepG2 Cells Mol. Cancer Res., September 1, 2007; 5(9): 923 - 932. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. B. Nicoud, C. D. Knox, C. M. Jones, C. D. Anderson, J. M. Pierce, A. E. Belous, T. M. Earl, and R. S. Chari 2-APB protects against liver ischemia-reperfusion injury by reducing cellular and mitochondrial calcium uptake Am J Physiol Gastrointest Liver Physiol, September 1, 2007; 293(3): G623 - G630. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Cui, S. Darmanin, M. Natsuisaka, T. Kondo, M. Asaka, M. Shindoh, F. Higashino, J. Hamuro, F. Okada, M. Kobayashi, et al. Enhanced Expression of Asparagine Synthetase under Glucose-Deprived Conditions Protects Pancreatic Cancer Cells from Apoptosis Induced by Glucose Deprivation and Cisplatin Cancer Res., April 1, 2007; 67(7): 3345 - 3355. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Laderoute, K. Amin, J. M. Calaoagan, M. Knapp, T. Le, J. Orduna, M. Foretz, and B. Viollet 5'-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments. Mol. Cell. Biol., July 1, 2006; 26(14): 5336 - 5347. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suzuki, T. Ogura, and H. Esumi NDR2 Acts as the Upstream Kinase of ARK5 during Insulin-like Growth Factor-1 Signaling J. Biol. Chem., May 19, 2006; 281(20): 13915 - 13921. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Land and C. Rae iNOS initiates and sustains metabolic arrest in hypoxic lung adenocarcinoma cells: mechanism of cell survival in solid tumor core Am J Physiol Cell Physiol, October 1, 2005; 289(4): C918 - C933. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suzuki, G.-i. Kusakai, Y. Shimojo, J. Chen, T. Ogura, M. Kobayashi, and H. Esumi Involvement of Transforming Growth Factor-{beta}1 Signaling in Hypoxia-induced Tolerance to Glucose Starvation J. Biol. Chem., September 9, 2005; 280(36): 31557 - 31563. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Suzuki, J. Lu, G.-i. Kusakai, A. Kishimoto, T. Ogura, and H. Esumi ARK5 Is a Tumor Invasion-Associated Factor Downstream of Akt Signaling Mol. Cell. Biol., April 15, 2004; 24(8): 3526 - 3535. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Rajendran, D. A. Mankoff, F. O'Sullivan, L. M. Peterson, D. L. Schwartz, E. U. Conrad, A. M. Spence, M. Muzi, D. G. Farwell, and K. A. Krohn Hypoxia and Glucose Metabolism in Malignant Tumors: Evaluation by [18F]Fluoromisonidazole and [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging Clin. Cancer Res., April 1, 2004; 10(7): 2245 - 2252. [Abstract] [Full Text] [PDF] |
||||